The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Abstract
At the stroke of the New Year 2020, COVID-19, a zoonotic disease that would turn into a global pandemic, was identified in the Chinese city of Wuhan. Although unique in its transmission and virulence, COVID-19 is similar to zoonotic diseases, including other SARS variants (e.g., SARS-CoV) and MERS, in exhibiting severe flu-like symptoms and acute respiratory distress. Even at the molecular level, many parallels have been identified between SARS and COVID-19 so much so that the COVID-19 virus has been named SARS-CoV-2. These similarities have provided several opportunities to treat COVID-19 patients using clinical approaches that were proven to be effective against SARS. Importantly, the identification of similarities in how SARS-CoV and SARS-CoV-2 access the host, replicate, and trigger life-threatening pathological conditions have revealed opportunities to repurpose drugs that were proven to be effective against SARS. In this article, we first provided an overview of COVID-19 etiology vis-à-vis other zoonotic diseases, particularly SARS and MERS. Then, we summarized the characteristics of droplets/aerosols emitted by COVID-19 patients and how they aid in the transmission of the virus among people. Moreover, we discussed the molecular mechanisms that enable SARS-CoV-2 to access the host and become more contagious than other betacoronaviruses such as SARS-CoV. Further, we outlined various approaches that are currently being employed to diagnose and symptomatically treat COVID-19 in the clinic. Finally, we reviewed various approaches and technologies employed to develop vaccines against COVID-19 and summarized the attempts to repurpose various classes of drugs and novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Self-citationAerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Self-citationChu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Schünemann, H. J., Chu, D. K., Akl, E. A., El-harakeh, A., Bognanni, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31142-9 · Cited by 3,843
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0754-0 · Cited by 2,287
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,205
SARS-CoV-2 vaccines in development
Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977
Xie, X., Zhong, Z., Zhao, W., Zheng, C., Wang, F., & Liu, J. (2020) · Radiology · doi:10.1148/radiol.2020200343 · Cited by 1,960
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14830 · Cited by 1,806
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Hematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S., & Griffith, B. (2020) · Radiology · doi:10.1148/radiol.2020201187 · Cited by 1,505
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488
Development of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCOVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Dong, L., Hu, S., & Gao, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.01012 · Cited by 1,390
The Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,346
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa330 · Cited by 1,326
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K. A., Lofgren, S. M., Okafor, E. C., Skipper, C. P., Nascene, A. A., Nicol, M. R., Abassi, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2016638 · Cited by 1,318
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Chen, P., Nirula, A., Heller, B., Gottlieb, R. L., Boscia, J., Morris, J., Huhn, G., Cardona, J., Mocherla, B., Stosor, V., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029849 · Cited by 1,282
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., et al. (2020) · Science · doi:10.1126/science.abd0831 · Cited by 1,253
Jayaweera, M., Perera, H., Gunawardana, B., & Manatunge, J. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109819 · Cited by 1,238
Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31605-6 · Cited by 1,225
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Han, H., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X.-H., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,223
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Hansen, J., Baum, A., Pascal, K. E., Russo, V., Giordano, S., Wloga, E., Fulton, B. O., Yan, Y., Koon, K., Patel, K., et al. (2020) · Science · doi:10.1126/science.abd0827 · Cited by 1,210
Zhao, W., Zhong, Z., Xie, X., Yu, Q., & Liu, J. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22976 · Cited by 1,209
Sungnak, W., Huang, N., Bécavin, C., & Berg, M. (2020) · PubMed · Cited by 1,196
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Keech, C., Albert, G., Cho, I., Robertson, A., Reed, P., Neal, S., Plested, J. S., Zhu, M., Cloney-Clark, S., Zhou, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026920 · Cited by 1,156
COVID-19, SARS and MERS: are they closely related?
Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G., & Petersen, E. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.026 · Cited by 1,108
Bourouiba, L. (2020) · JAMA · doi:10.1001/jama.2020.4756 · Cited by 1,066
Convalescent plasma as a potential therapy for COVID-19
Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30141-9 · Cited by 1,038
Deposition of particles in the human respiratory tract in the size range 0.005–15 μm
Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., & Stahlhofen, W. (1986) · Journal of Aerosol Science · doi:10.1016/0021-8502(86)90035-2 · Cited by 1,026
AIRBORNE SPREAD OF MEASLES IN A SUBURBAN ELEMENTARY SCHOOL
RILEY, E. C., MURPHY, G., & RILEY, R. L. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112560 · Cited by 932
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
Lin, L., Jiang, X., Zhang, Z., Huang, S., Zhang, Z., Fang, Z., Gu, Z., Gao, L., Shi, H., Mai, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321013 · Cited by 924
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
Violent expiratory events: on coughing and sneezing
Bourouiba, L., Dehandschoewercker, E., & Bush, J. W. M. (2014) · Journal of Fluid Mechanics · doi:10.1017/jfm.2014.88 · Cited by 828
Rapid COVID-19 vaccine development
Graham, B. S. (2020) · Science · doi:10.1126/science.abb8923 · Cited by 771
Xia, S., Duan, K., Zhang, Y., Zhao, D., Zhang, H., Xie, Z., Li, X., Peng, C., Zhang, Y., Zhang, W., et al. (2020) · JAMA · doi:10.1001/jama.2020.15543 · Cited by 759
Findings of lung ultrasonography of novel corona virus pneumonia during the 2019–2020 epidemic
Chinese Critical Care Ultrasound Study Group (CCUSG), Peng, Q.-Y., Wang, X.-T., & Zhang, L.-N. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05996-6 · Cited by 737
The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles?
Asadi, S., Bouvier, N., Wexler, A. S., & Ristenpart, W. D. (2020) · Aerosol Science and Technology · doi:10.1080/02786826.2020.1749229 · Cited by 680
Peptide Vaccine: Progress and Challenges
Li, W., Joshi, M., Singhania, S., Ramsey, K., & Murthy, A. (2014) · Vaccines · doi:10.3390/vaccines2030515 · Cited by 679
Modality of human expired aerosol size distributions
Johnson, G. R., Morawska, L., Ristovski, Z. D., Hargreaves, M., Mengersen, K., Chao, C. Y. H., Wan, M. P., Li, Y., Xie, X., Katoshevski, D., et al. (2011) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2011.07.009 · Cited by 655
Grant, M. C., Geoghegan, L., Arbyn, M., Mohammed, Z., McGuinness, L., Clarke, E. L., & Wade, R. G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234765 · Cited by 649
Deeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 644
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Immunogenicity of a DNA vaccine candidate for COVID-19
Smith, T. R. F., Patel, A., Ramos, S., Elwood, D., Zhu, X., Yan, J., Gary, E. N., Walker, S. N., Schultheis, K., Purwar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16505-0 · Cited by 601
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 572
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555
Host Factors in Coronavirus Replication
de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2017) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2017_25 · Cited by 546
Ssentongo, P., Ssentongo, A. E., Heilbrunn, E. S., Ba, D. M., & Chinchilli, V. M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238215 · Cited by 532
Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research
McAloon, C., Collins, Á., Hunt, K., Barber, A., Byrne, A. W., Butler, F., Casey, M., Griffin, J., Lane, E., McEvoy, D., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039652 · Cited by 527
The SARS-CoV-2 Vaccine Pipeline: an Overview
Chen, W.-H., Strych, U., Hotez, P. J., & Bottazzi, M. E. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00201-6 · Cited by 511
The cell biology of receptor-mediated virus entry
Grove, J., & Marsh, M. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108131 · Cited by 510
Madissoon, E., Wilbrey-Clark, A., Miragaia, R. J., Saeb-Parsy, K., Mahbubani, K. T., Georgakopoulos, N., Harding, P., Polanski, K., Huang, N., Nowicki-Osuch, K., et al. (2020) · Genome Biology · doi:10.1186/s13059-019-1906-x · Cited by 498
Zhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., Li, Z., Cui, X., Xiao, J., Zhan, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320953 · Cited by 498
Omrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0773 · Cited by 486
Arbidol as a broad-spectrum antiviral: An update
Blaising, J., Polyak, S. J., & Pécheur, E.-I. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.04.006 · Cited by 485
Wildlife as Source of Zoonotic Infections
Kruse, H., Kirkemo, A.-M., & Handeland, K. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1012.040707 · Cited by 482
Pulmonary fibrosis secondary to COVID-19: a call to arms?
Spagnolo, P., Balestro, E., Aliberti, S., Cocconcelli, E., Biondini, D., Casa, G. D., Sverzellati, N., & Maher, T. M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30222-8 · Cited by 481
The Size and Concentration of Droplets Generated by Coughing in Human Subjects
Yang, S., Lee, G. W. M., Chen, C.-M., Wu, C.-C., & Yu, K.-P. (2007) · Journal of Aerosol Medicine · doi:10.1089/jam.2007.0610 · Cited by 473
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Joyner, M. J., Wright, R. S., Fairweather, D., Senefeld, J. W., Bruno, K. A., Klassen, S. A., Carter, R. E., Klompas, A. M., Wiggins, C. C., Shepherd, J. R. A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140200 · Cited by 471
Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447
Encephalitis as a clinical manifestation of COVID-19
Ye, M., Ren, Y., & Lv, T. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.017 · Cited by 429
Kai, H., & Kai, M. (2020) · Hypertension Research · doi:10.1038/s41440-020-0455-8 · Cited by 426
Tocilizumab: A review in rheumatoid arthritis
Scott, L. J. (2017) · Drugs · doi:10.1007/s40265-017-0829-7 · Cited by 419
Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19
Gostic, K., Gomez, A. C., Mummah, R. O., Kucharski, A. J., & Lloyd-Smith, J. O. (2020) · eLife · doi:10.7554/elife.55570 · Cited by 417
The Pathogenesis of Ebola Virus Disease
Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100506 · Cited by 404
The establishment of resident memory B cells in the lung requires local antigen encounter
Allie, S. R., Bradley, J. E., Mudunuru, U., Schultz, M. D., Graf, B. A., Lund, F. E., & Randall, T. D. (2019) · Nature Immunology · doi:10.1038/s41590-018-0260-6 · Cited by 396
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A. F., & Osswald, S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa235 · Cited by 395
Byrne, A. W., McEvoy, D., Collins, A. B., Hunt, K., Casey, M., Barber, A., Butler, F., Griffin, J., Lane, E. A., McAloon, C., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039856 · Cited by 387
COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis
Angeletti, S., Benvenuto, D., Bianchi, M., Giovanetti, M., Pascarella, S., & Ciccozzi, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25719 · Cited by 386
Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis
Kronbichler, A., Kresse, D., Yoon, S., Lee, K. H., Effenberger, M., & Shin, J. I. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.052 · Cited by 385
Characterizations of particle size distribution of the droplets exhaled by sneeze
Han, Z. Y., Weng, W. G., & Huang, Q. Y. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0560 · Cited by 383
Sze To, G. N., & Chao, C. Y. H. (2010) · Indoor Air · doi:10.1111/j.1600-0668.2009.00621.x · Cited by 383
Joyner, M. J., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., Lesser, E. R., et al. (2020) · medRxiv · doi:10.1101/2020.08.12.20169359 · Cited by 337
Caring for patients with cancer in the COVID-19 era
van de Haar, J., Hoes, L. R., Coles, C. E., Seamon, K., Fröhling, S., Jäger, D., Valenza, F., de Braud, F., De Petris, L., Bergh, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0874-8 · Cited by 330
Wilson, N. M., Norton, A., Young, F. P., & Collins, D. W. (2020) · Anaesthesia · doi:10.1111/anae.15093 · Cited by 329
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01744-7 · Cited by 327
Diurno, F., Numis, F. G., Porta, G., Cirillo, F., Maddaluno, S., Ragozzino, A., Negri, P. D., Gennaro, C. D., Pagano, A., Allegorico, E., et al. (2020) · PubMed · doi:10.26355/eurrev_202004_20875 · Cited by 326
Recent Advances in Subunit Vaccine Carriers
Vartak, A., & Sucheck, S. (2016) · Vaccines · doi:10.3390/vaccines4020012 · Cited by 323
Faecal calprotectin indicates intestinal inflammation in COVID-19
Effenberger, M., Grabherr, F., Mayr, L., Schwaerzler, J., Nairz, M., Seifert, M., Hilbe, R., Seiwald, S., Scholl-Buergi, S., Fritsche, G., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321388 · Cited by 305
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City
Frontera, J. A., Sabadia, S., Lalchan, R., Fang, T., Flusty, B., Millar-Vernetti, P., Snyder, T., Berger, S., Yang, D., Granger, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000010979 · Cited by 291
Zhang, J. J. Y., Lee, K. S., Ang, L. W., Leo, Y. S., & Young, B. E. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa576 · Cited by 285
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Marovich, M., Mascola, J. R., & Cohen, M. S. (2020) · JAMA · doi:10.1001/jama.2020.10245 · Cited by 275
Li, Z., Liu, T., Yang, N., Han, D., Mi, X., Li, Y., Liu, K., Vuylsteke, A., Xiang, H., & Guo, X. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0786-5 · Cited by 269
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Zhou, G., & Zhao, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45123 · Cited by 266
The Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263
Neurotropism of SARS-CoV 2: Mechanisms and manifestations
Conde Cardona, G., Quintana Pájaro, L. D., Quintero Marzola, I. D., Ramos Villegas, Y., & Moscote Salazar, L. R. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116824 · Cited by 261
Cheng, Y.-W., Chao, T.-L., Li, C.-L., Chiu, M.-F., Kao, H.-C., Wang, S.-H., Pang, Y.-H., Lin, C.-H., Tsai, Y.-M., Lee, W.-H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108254 · Cited by 257
Self-citationSingh, A. K., Majumdar, S., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.054 · Cited by 252
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
Kalita, P., Padhi, A. K., Zhang, K. Y. J., & Tripathi, T. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104236 · Cited by 234
Zayas, G., Chiang, M. C., Wong, E., MacDonald, F., Lange, C. F., Senthilselvan, A., & King, M. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-11 · Cited by 227
Manchikanti, L. (2020) · Pain Physician · doi:10.36076/ppj.2020/23/e71 · Cited by 227
Tandrup Schmidt, S., Foged, C., Smith Korsholm, K., Rades, T., & Christensen, D. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8010007 · Cited by 213
DNA vaccines: roles against diseases
Khan, K. H. (2013) · GERMS · doi:10.11599/germs.2013.1034 · Cited by 212
Xu, J., Xu, X., Jiang, L., Dua, K., Hansbro, P. M., & Liu, G. (2020) · Respiratory Research · doi:10.1186/s12931-020-01445-6 · Cited by 198
Guy, J. L., Jackson, R. M., Acharya, K. R., Sturrock, E. D., Hooper, N. M., & Turner, A. J. (2003) · Biochemistry · doi:10.1021/bi035268s · Cited by 189
Diabetes and COVID-19: evidence, current status and unanswered research questions
Gupta, R., Hussain, A., & Misra, A. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0652-1 · Cited by 182
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
Rico-Mesa, J. S., White, A., & Anderson, A. S. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01291-4 · Cited by 177
Monoclonal antibody as a potential anti-COVID-19
Jahanshahlu, L., & Rezaei, N. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110337 · Cited by 170
Treatment and Prevention of Pandemic H1N1 Influenza
Rewar, S., Mirdha, D., & Rewar, P. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2015.08.014 · Cited by 165
Sanders, B., Koldijk, M., & Schuitemaker, H. (2015) · Vaccine Analysis: Strategies, Principles, and Control · doi:10.1007/978-3-662-45024-6_2 · Cited by 159
Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
Ols, S., Yang, L., Thompson, E. A., Pushparaj, P., Tran, K., Liang, F., Lin, A., Eriksson, B. M., Hedestam, G. B. K., Wyatt, R. T., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.111 · Cited by 151
Noakes, C. J., & Sleigh, A. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0305.focus · Cited by 142
Jiang, S., Bottazzi, M. E., Du, L., Lustigman, S., Tseng, C.-T. K., Curti, E., Jones, K. M., Zhan, B., & Hotez, P. J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.126 · Cited by 137
Strategies for intranasal delivery of vaccines
Zaman, M., Chandrudu, S., & Tóth, I. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0085-z · Cited by 130
Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow
Garraud, O., Heshmati, F., Pozzetto, B., Lefrère, F., Girot, R., Saillol, A., & Laperche, S. (2016) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2015.12.003 · Cited by 130
Monoclonal Antibodies for Emerging Infectious Diseases — Borrowing from History
Marston, H. D., Paules, C. I., & Fauci, A. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1802256 · Cited by 125
Fedson, D. S. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.11.03 · Cited by 124
Magro, F., Lopes, J., Borralho, P., Lopes, S., Coelho, R., Cotter, J. B., de Castro, F. D., de Sousa, H. T., Salgado, M., Andrade, P., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315545 · Cited by 123
The immunogenicity of intracerebral virus infection depends on anatomical site
Stevenson, P. G., Hawke, S., Sloan, D. J., & Bangham, C. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.145-151.1997 · Cited by 114
Tebas, P., Kraynyak, K. A., Patel, A. R., Maslow, J. N., Morrow, M. P., Sylvester, A. J., Knoblock, D. M., Gillespie, E. B., Amante, D. H., Racine, T., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz132 · Cited by 113
Adenoviral vector-based strategies against infectious disease and cancer
Zhang, C., & Zhou, D. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1165908 · Cited by 110
The numbers and the sites of origin of the droplets expelled during expiratory activities.
Jp, D. (1945) · PubMed Central · Cited by 106
Sorrentino, S. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050207 · Cited by 105
Bourouiba, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmicm1501197 · Cited by 104
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
Samaee, H., Mohsenzadegan, M., Ala, S., Maroufi, S. S., & Moradimajd, P. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107018 · Cited by 103
Gupta, T., & Gupta, S. K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106717 · Cited by 90
Interferons in Autoimmune and Inflammatory Diseases: Regulation and Roles
Choubey, D., & Moudgil, K. D. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0101 · Cited by 84
Abassi, Z. A., Skorecki, K. L., Heyman, S. N., Kinaneh, S., & Armaly, Z. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00097.2020 · Cited by 83
Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement
Khalaj‐Hedayati, A., Chua, C. L. L., Smooker, P. M., & Lee, K. W. (2019) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12697 · Cited by 81
Mathewson, A. C., Bishop, A., Yao, Y., Kemp, F., Ren, J., Chen, H., Xu, X., Berkhout, B., van der Hoek, L., & Jones, I. M. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/003962-0 · Cited by 80
Origins of the Spanish Influenza pandemic (1918-1920) and its relation to the First World War
Barrena, A. E. (2009) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000033 · Cited by 79
Ghayda, R. A., Lee, J., Lee, J. Y., Kim, D. K., Lee, K. H., Hong, S. H., Han, Y. J., Kim, J., Yang, J. W., Kronbichler, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145026 · Cited by 76
ON THE MECHANICS OF DROPLET NUCLEI INFECTION
Wells, W. F., Ratcliffe, H. L., & Crumb, C. (1948) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119179 · Cited by 75
Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection
CHEN, S. C., Chio, C., Jou, L., & Liao, C. (2009) · Indoor Air · doi:10.1111/j.1600-0668.2009.00603.x · Cited by 60
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities
Wang, J. J., Edin, M. L., Zeldin, D. C., Li, C., Wang, D. W., & Chen, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107628 · Cited by 58
Self-citationThe innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
Madsen, C. (2017) · Brain and Behavior · doi:10.1002/brb3.696 · Cited by 56
In vitro inactivation of the rabies virus by ascorbic acid
Madhusudana, S. N., Shamsundar, R., & Seetharaman, S. (2003) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.09.002 · Cited by 53
Polyomavirus inactivation – A review
Nims, R. W., & Plavsic, M. Z. (2012) · Biologicals · doi:10.1016/j.biologicals.2012.09.011 · Cited by 46
Management of patients with COPD during the COVID-19 pandemic
Attaway, A. H., & Hatipoglu, U. S. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc007 · Cited by 33
ON THE MECHANICS OF DROPLET NUCLEI INFECTION
Wells, W. F. (1948) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119176 · Cited by 32
Mirzaei, R., Mohammadzadeh, R., Mahdavi, F., Badrzadeh, F., Kazemi, S., Ebrahimi, M., soltani, F., Kazemi, S., Jeda, A. S., Darvishmotevalli, M., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106928 · Cited by 29
Prone positioning in non-intubated patients with COVID-19: raising the bar
Munshi, L., Fralick, M., & Fan, E. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30269-1 · Cited by 21
Cure, M. C., Küçük, A., & Cüre, E. (2020) · Therapies · doi:10.1016/j.therap.2020.06.012 · Cited by 18
Kang, J., Kao, L., Lin, H., Wang, T.-J., & Yang, T.-Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199981 · Cited by 15
Cited by
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Schultheiß, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Henkes, S.-S., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100663 · Cited by 431
Metadata
- Authors
- Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S., Li, C., Kandimalla, M., Tang, X., Carmona Porquera, E. M., Kalari, K. R., & Kandimalla, K. K.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-01-19
- Volume
- 18
- Issue
- 3
- Pages
- 754-771
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W3124815682
- Cited by
- 315
- References
- 170
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.